FDA Inspection 1103474 — Michael M. Dao, M.D.
The FDA completed an inspection of Michael M. Dao, M.D. on July 18, 2019 in Garden Grove, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Garden Grove, CA (United States)
Additional Details
Clinical Investigator (CI)